1394 related articles for article (PubMed ID: 15028262)
1. Topoisomerase I-mediated DNA cleavage as a guide to the development of antitumor agents derived from the marine alkaloid lamellarin D: triester derivatives incorporating amino acid residues.
Tardy C; Facompré M; Laine W; Baldeyrou B; García-Gravalos D; Francesch A; Mateo C; Pastor A; Jiménez JA; Manzanares I; Cuevas C; Bailly C
Bioorg Med Chem; 2004 Apr; 12(7):1697-712. PubMed ID: 15028262
[TBL] [Abstract][Full Text] [Related]
2. Lamellarin D: a novel potent inhibitor of topoisomerase I.
Facompré M; Tardy C; Bal-Mahieu C; Colson P; Perez C; Manzanares I; Cuevas C; Bailly C
Cancer Res; 2003 Nov; 63(21):7392-9. PubMed ID: 14612538
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and structure-activity relationship study of potent cytotoxic analogues of the marine alkaloid Lamellarin D.
Pla D; Marchal A; Olsen CA; Francesch A; Cuevas C; Albericio F; Alvarez M
J Med Chem; 2006 Jun; 49(11):3257-68. PubMed ID: 16722644
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and topoisomerase I inhibitory activity of a novel diazaindeno[2,1-b]phenanthrene analogue of Lamellarin D.
Cananzi S; Merlini L; Artali R; Beretta GL; Zaffaroni N; Dallavalle S
Bioorg Med Chem; 2011 Aug; 19(16):4971-84. PubMed ID: 21783369
[TBL] [Abstract][Full Text] [Related]
5. Lamellarin D: a novel pro-apoptotic agent from marine origin insensitive to P-glycoprotein-mediated drug efflux.
Vanhuyse M; Kluza J; Tardy C; Otero G; Cuevas C; Bailly C; Lansiaux A
Cancer Lett; 2005 Apr; 221(2):165-75. PubMed ID: 15808402
[TBL] [Abstract][Full Text] [Related]
6. Design, Synthesis and Structure-Activity Relationship Studies of Glycosylated Derivatives of Marine Natural Product Lamellarin D.
Zheng L; Gao T; Ge Z; Ma Z; Xu J; Ding W; Shen L
Eur J Med Chem; 2021 Mar; 214():113226. PubMed ID: 33582387
[TBL] [Abstract][Full Text] [Related]
7. Design and total synthesis of Mannich derivatives of marine natural product lamellarin D as cytotoxic agents.
Shen L; Xie N; Yang B; Hu Y; Zhang Y
Eur J Med Chem; 2014 Oct; 85():807-17. PubMed ID: 25189362
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and biological evaluation of a D-ring-contracted analogue of lamellarin D.
Colligs V; Hansen SP; Imbri D; Seo EJ; Kadioglu O; Efferth T; Opatz T
Bioorg Med Chem; 2017 Nov; 25(22):6137-6148. PubMed ID: 28233677
[TBL] [Abstract][Full Text] [Related]
9. Lamellarin D bioconjugates I: Synthesis and cellular internalization of PEG-derivatives.
Pla D; Francesch A; Calvo P; Cuevas C; Aligué R; Albericio F; Alvarez M
Bioconjug Chem; 2009 Jun; 20(6):1100-11. PubMed ID: 19472995
[TBL] [Abstract][Full Text] [Related]
10. Molecular determinants of topoisomerase I poisoning by lamellarins: comparison with camptothecin and structure-activity relationships.
Marco E; Laine W; Tardy C; Lansiaux A; Iwao M; Ishibashi F; Bailly C; Gago F
J Med Chem; 2005 Jun; 48(11):3796-807. PubMed ID: 15916431
[TBL] [Abstract][Full Text] [Related]
11. Design and synthesis of lamellarin D analogues targeting topoisomerase I.
Ohta T; Fukuda T; Ishibashi F; Iwao M
J Org Chem; 2009 Nov; 74(21):8143-53. PubMed ID: 19791738
[TBL] [Abstract][Full Text] [Related]
12. Lamellarin-inspired potent topoisomerase I inhibitors with the unprecedented benzo[g][1]benzopyrano[4,3-b]indol-6(13H)-one scaffold.
Fukuda T; Nanjo Y; Fujimoto M; Yoshida K; Natsui Y; Ishibashi F; Okazaki F; To H; Iwao M
Bioorg Med Chem; 2019 Jan; 27(2):265-277. PubMed ID: 30553626
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis and systematic evaluation of cytotoxic 3-heteroarylisoquinolinamines as topoisomerases inhibitors.
My Van HT; Woo H; Jeong HM; Khadka DB; Yang SH; Zhao C; Jin Y; Lee ES; Youl Lee K; Kwon Y; Cho WJ
Eur J Med Chem; 2014 Jul; 82():181-94. PubMed ID: 24904965
[TBL] [Abstract][Full Text] [Related]
14. Lamellarin D bioconjugates II: Synthesis and cellular internalization of dendrimer and nuclear location signal derivatives.
Pla D; Martí M; Farrera-Sinfreu J; Pulido D; Francesch A; Calvo P; Cuevas C; Royo M; Aligué R; Albericio F; Alvarez M
Bioconjug Chem; 2009 Jun; 20(6):1112-21. PubMed ID: 19472996
[TBL] [Abstract][Full Text] [Related]
15. Modular total synthesis of lamellarin D.
Pla D; Marchal A; Olsen CA; Albericio F; Alvarez M
J Org Chem; 2005 Sep; 70(20):8231-4. PubMed ID: 16277357
[TBL] [Abstract][Full Text] [Related]
16. Cancer cell mitochondria are direct proapoptotic targets for the marine antitumor drug lamellarin D.
Kluza J; Gallego MA; Loyens A; Beauvillain JC; Sousa-Faro JM; Cuevas C; Marchetti P; Bailly C
Cancer Res; 2006 Mar; 66(6):3177-87. PubMed ID: 16540669
[TBL] [Abstract][Full Text] [Related]
17. Synthesis of chromeno[3,4-b]indoles as Lamellarin D analogues: a novel DYRK1A inhibitor class.
Neagoie C; Vedrenne E; Buron F; Mérour JY; Rosca S; Bourg S; Lozach O; Meijer L; Baldeyrou B; Lansiaux A; Routier S
Eur J Med Chem; 2012 Mar; 49():379-96. PubMed ID: 22305342
[TBL] [Abstract][Full Text] [Related]
18. Poisoning of mitochondrial topoisomerase I by lamellarin D.
Khiati S; Seol Y; Agama K; Dalla Rosa I; Agrawal S; Fesen K; Zhang H; Neuman KC; Pommier Y
Mol Pharmacol; 2014 Aug; 86(2):193-9. PubMed ID: 24890608
[TBL] [Abstract][Full Text] [Related]
19. Synthesis of benzo[3,4]azepino[1,2-b]isoquinolin-9-ones from 3-arylisoquinolines via ring closing metathesis and evaluation of topoisomerase I inhibitory activity, cytotoxicity and docking study.
Van HT; Khadka DB; Yang SH; Le TN; Cho SH; Zhao C; Lee IS; Kwon Y; Lee KT; Kim YC; Cho WJ
Bioorg Med Chem; 2011 Sep; 19(18):5311-20. PubMed ID: 21873069
[TBL] [Abstract][Full Text] [Related]
20. Cytotoxicities and structure-activity relationships of natural and unnatural lamellarins toward cancer cell lines.
Chittchang M; Batsomboon P; Ruchirawat S; Ploypradith P
ChemMedChem; 2009 Mar; 4(3):457-65. PubMed ID: 19152364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]